VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1555356
Sex: F
Age: 52
State: FL

Vax Date: 02/17/2021
Onset Date: 02/22/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: rashes on the right hand; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Feb-2021 and was forwarded to Moderna on 24-Feb-2021. This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (rashes on the right hand) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced RASH (rashes on the right hand). At the time of the report, RASH (rashes on the right hand) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment information was not provided. concomitant information was not provided.

Other Meds:

Current Illness:

ID: 1555357
Sex: F
Age: 81
State: FL

Vax Date: 01/27/2021
Onset Date: 02/22/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Weird Voice; Vomited; Headache; Very Tired; Dizzy; Feels Sick; Runny nose; Joint pains; Body aches and pains; The chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Feels Sick), RHINORRHOEA (Runny nose), DIZZINESS (Dizzy), DYSPHONIA (Weird Voice) and ARTHRALGIA (Joint pains) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included PACLITAXEL (PAXEL), RIFABUTIN (RIBUTIN) and ATORVASTATIN for an unknown indication. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced ILLNESS (Feels Sick), RHINORRHOEA (Runny nose), ARTHRALGIA (Joint pains), MYALGIA (Body aches and pains) and CHILLS (The chills). On 23-Feb-2021, the patient experienced DIZZINESS (Dizzy). 23-Feb-2021, the patient experienced VOMITING (Vomited), HEADACHE (Headache) and FATIGUE (Very Tired). On 24-Feb-2021, the patient experienced DYSPHONIA (Weird Voice). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ILLNESS (Feels Sick), RHINORRHOEA (Runny nose), DIZZINESS (Dizzy), DYSPHONIA (Weird Voice), ARTHRALGIA (Joint pains), MYALGIA (Body aches and pains), CHILLS (The chills), VOMITING (Vomited), HEADACHE (Headache) and FATIGUE (Very Tired) outcome was unknown. Action taken with mRNA-1273 in response to the event was not applicable. Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Non-Significant Follow-up received on 14-July-2021 and contains updated reporter contact information

Other Meds: PAXEL; RIBUTIN; ATORVASTATIN

Current Illness:

ID: 1555358
Sex: F
Age: 80
State: NJ

Vax Date: 02/23/2021
Onset Date: 02/23/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: not normal ear wax "large amount of gunk" was removed from her ear; clogged ear sensation; hearing diminished; truble lifiting arm; horrible headache; Tiredness; I had audio high pitch sound; Vaccination site pain; Felt like medication was coming out of arm; This spontaneous case was reported by a consumer and describes the occurrence of EXCESSIVE CERUMEN PRODUCTION (not normal ear wax "large amount of gunk" was removed from her ear), TINNITUS (I had audio high pitch sound), VACCINATION SITE PAIN (Vaccination site pain), FEELING ABNORMAL (Felt like medication was coming out of arm) and EAR DISCOMFORT (clogged ear sensation) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 23-Feb-2021 at 10:45 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced TINNITUS (I had audio high pitch sound), VACCINATION SITE PAIN (Vaccination site pain), FEELING ABNORMAL (Felt like medication was coming out of arm), LIMB DISCOMFORT (truble lifiting arm), HEADACHE (horrible headache) and FATIGUE (Tiredness). On an unknown date, the patient experienced EXCESSIVE CERUMEN PRODUCTION (not normal ear wax "large amount of gunk" was removed from her ear), EAR DISCOMFORT (clogged ear sensation) and HYPOACUSIS (hearing diminished). At the time of the report, EXCESSIVE CERUMEN PRODUCTION (not normal ear wax "large amount of gunk" was removed from her ear), TINNITUS (I had audio high pitch sound), FEELING ABNORMAL (Felt like medication was coming out of arm), EAR DISCOMFORT (clogged ear sensation), HYPOACUSIS (hearing diminished), LIMB DISCOMFORT (truble lifiting arm), HEADACHE (horrible headache) and FATIGUE (Tiredness) outcome was unknown and VACCINATION SITE PAIN (Vaccination site pain) had not resolved. No concomitant medications were provided. No treatment medications were provided. Patient had a similar side effect after receiving both doses of the Moderna COVID-19 vaccine. This case was linked to MOD21-123712 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: patient demographics updated: initials, date of birth & age. On 26-Jul-2021: events updated- chunk of gunk, clogged ear, not normal wax, hearing diminished

Other Meds:

Current Illness:

ID: 1555359
Sex: F
Age: 78
State: NY

Vax Date: 01/27/2021
Onset Date: 01/28/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sciatica; very painful going from back to the ankle; couldn't do anything for 2 weeks because of the pain; A spontaneous report was received from a consumer article concerning a 78 years old, female patient who developed/experienced Sciatica,very painful going from back to the ankle,couldn't do anything for 2 weeks because of the pain. The patient medical history was not provided.Concomitant product use was not provided/unknown by the reporter. On 27-JAN-2021,prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number:032L2OA intramuscularly in the unknown site for prophylaxis of COVID-19 infection On 24-FEB-2021,prior to the onset of the symptoms, the patient received their second of two planned doses of mRNA-1273 (Batch number:023M20A intramuscularly in the unknown site for prophylaxis of COVID-19 infection. On 27-JAN-2021,the patient experienced the events Sciatica,very painful going from back to the ankle,couldn't do anything for 2 weeks because of the pain. Treatment information included Advil and aspercreme with 4% lidocaine in it Action taken with mRNA with response to events was not provided. On an unknown date,sciatica,very painful going from back to the ankle ,couldn't do anything for 2 weeks because of the pain was unknown.

Other Meds:

Current Illness:

ID: 1555360
Sex: F
Age:
State: NC

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: for 48 hr high fever; for 48 hr chills.; very red hives (2 by 3 inches) it burns; very red hives (2 by 3 inches) it burns; A spontaneous report was received from a healthcare professional concerning a Drug Start Date-1947-1-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events for 48 hr high fever and chills, very red hives (2 by 3 inches) and it burns. The patient's medical history was not provided. No relevant concomitant medications were reported. On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 0X8L20A) intramuscularly for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced the events for 48 hr high fever and chills, very red hives (2 by 3 inches) and it burns. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of events for 48 hr high fever and chills, very red hives (2 by 3 inches) and it burns were unknown.

Other Meds:

Current Illness:

ID: 1555361
Sex: M
Age:
State: MA

Vax Date: 01/16/2021
Onset Date: 01/17/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fatigue; Arm pain; Fever - Temperature of 100.4F; Arm pain; A spontaneous report was received from a Consumer concerning her husband ? 67 Years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events Fatigue,Injection site pain and Pyrexia. The patient's medical history was not provided. No relevant concomitant medications were reported. On 16-Jan-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch:unknown) intramuscularly in the right arm for prophylaxis of COVID-19 infection. On 13-Feb-2021, the patient received second of two planned doses of mRNA-1273 (lot/batch:unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 17-Jan-2021, The patient experienced the event arm pain and on 14-Feb-2021 the patient experienced the events Fatigue,Injection site pain and Fever - Temperature of 100.4F. Laboratory details was not provided. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. On 17-JAN-2021, the outcome of the event Arm pain was recoverd/resolved and on 14-FEB-2021 the outcome of the events Fatigue was recoverd/resolved,Injection site pain was recoverd/resolved and Fever - Temperature of 100.4F was recoverd/resolved The reporter assessed the events arm pain, Fatigue,Injection site pain and Fever - Temperature of 100.4F related to study drug is unknown.

Other Meds:

Current Illness:

ID: 1555362
Sex: F
Age: 82
State: FL

Vax Date: 01/09/2021
Onset Date: 01/17/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red arm; Swollen arm; Arm angry and hot; Feeling Uncomfortable; A spontaneous report was received from an 82-years-old patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced red arm/erythema,swollen arm/peripheral swelling, angry,hot arm/ paraesthesia and feeling uncomfortable / discomfort. The patient's medical history was not provided Concomitant product use was not provided/unknown by the reporter. On 9 Jan 2021, prior to the onset of the events ,the patient received their first of two planned doses of mRNA-1273 (lot/batch: 011L20A)via unknown route in the left arm for prophylaxis of COVID-19 infection. On 17 Jan 2021, the patient experienced red ,swollen ,angry and hot arm and were feeling uncomfortable. Treatment included ice and cool damp rag. Action taken with mRNA-1273 in response to the events was unknown. The outcome of event ,swollen,hot arm and feeling uncomfortable were considered to be resolving.The outcome of the event, red arm was considered to be resolved.

Other Meds:

Current Illness:

ID: 1555363
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: having a very bad experience; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events having a very bad experience. The patient's medical history was not provided. No relevant concomitant medications were reported. On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unk) via unknown route for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced the event(s) having a very bad experience. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), having a very bad experience was unknown.

Other Meds:

Current Illness:

ID: 1555364
Sex: M
Age: 80
State: CA

Vax Date: 01/28/2021
Onset Date: 02/02/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; diarrhea, it's like brown water; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea, it's like brown water) and CHILLS (Chills) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (no reported medical history). On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced DIARRHOEA (diarrhea, it's like brown water). On 03-Feb-2021, the patient experienced CHILLS (Chills). On 03-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, DIARRHOEA (diarrhea, it's like brown water) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. Treatment details were not provided. Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.

Other Meds:

Current Illness:

ID: 1555365
Sex: F
Age: 67
State: NY

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Soreness in arm; A spontaneous report was received from a consumer concerning a 67-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events soreness in arm/pain in extremity. The patient's medical history was not provided. No relevant concomitant medications were reported. On unknown date, the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection. No adverse events reported to the first dose of the vaccine. On 24 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 013M20A) intramuscularly for prophylaxis of COVID-19 infection. On 24 Feb 2021, the patient experienced the event soreness in arm following administration of vaccine. No treatment information was provided. Since patient received both the scheduled doses of the vaccine action taken with mRNA-1273 in response to the events was not applicable. The outcome of event soreness in arm was not resolved.

Other Meds:

Current Illness: Drug allergy (bzd c)

ID: 1555366
Sex: M
Age: 70
State: WA

Vax Date: 02/24/2021
Onset Date: 02/25/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dry cough; Headache; Fatigue; Body ache; A spontaneous report was received from a consumer concerning a 70-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events headache, fatigue, body ache and dry cough. The patient's medical history was not provided. No relevant concomitant medications were reported. On 24 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Unknown) via unknown route in left arm for prophylaxis of COVID-19 infection. On 25 Feb 2021, the patient experienced the events headache, fatigue, body ache and dry cough. No treatment was taken by the patient. Action taken with mRNA-1273 in response to the events was not reported. The outcome of events headache, fatigue, body ache and dry cough was not resolved.

Other Meds:

Current Illness:

ID: 1555367
Sex: M
Age: 61
State: FL

Vax Date: 02/03/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Coughing; Body Aches; Fever; Chills; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing), PAIN (Body Aches), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headaches) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03IL20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 (Patient was diagnosed in last December with COVID) in December 2020. Concomitant products included SIMVASTATIN and LEVOTHYROXINE for an unknown indication. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COUGH (Coughing), PAIN (Body Aches), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headaches). At the time of the report, COUGH (Coughing), PAIN (Body Aches), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headaches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.

Other Meds: SIMVASTATIN; LEVOTHYROXINE

Current Illness:

ID: 1555368
Sex: F
Age: 59
State: OH

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Diarrhea; Tiredness; Redness around injection site; This spontaneous case was reported by a nurse and describes the occurrence of DIARRHOEA (Diarrhea), FATIGUE (Tiredness) and VACCINATION SITE ERYTHEMA (Redness around injection site) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 013M20A) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced DIARRHOEA (Diarrhea), FATIGUE (Tiredness) and VACCINATION SITE ERYTHEMA (Redness around injection site). On 23-Jan-2021, DIARRHOEA (Diarrhea) and FATIGUE (Tiredness) had resolved. On 28-Jan-2021, VACCINATION SITE ERYTHEMA (Redness around injection site) had resolved. Possible For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1555369
Sex: F
Age: 70
State: NJ

Vax Date: 01/18/2021
Onset Date: 01/01/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Irritable bowel syndrome; Dry eyes; occular migraines; reflux severe; This spontaneous case was reported by a consumer and describes the occurrence of DRY EYE (Dry eyes), RETINAL MIGRAINE (occular migraines), GASTROOESOPHAGEAL REFLUX DISEASE (reflux severe) and IRRITABLE BOWEL SYNDROME (Irritable bowel syndrome) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 011L20A) for COVID-19 vaccination. Concurrent medical conditions included Hashimoto's disease since June 2007, Raynaud's syndrome, Migraine since 07-Jan-2021, Drug allergy, Drug allergy and Drug allergy. Concomitant products included THYROID (ARMOUR THYROID) for Hashimoto's thyroiditis, ACEBUTOLOL for Premature ventricular contractions, AMLODIPINE for Premature ventricular contractions, Raynaud's syndrome and Blood pressure, CALCIUM LACTATE, CALCIUM PHOSPHATE, COLECALCIFEROL (CALCIUM & VITAMIN D [CALCIUM LACTATE;CALCIUM PHOSPHATE;COLECALCIFEROL]) and ASCORBIC ACID, ZINC CITRATE (ZINC + VITAMIN C) for an unknown indication. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In January 2021, the patient experienced RETINAL MIGRAINE (occular migraines) and GASTROOESOPHAGEAL REFLUX DISEASE (reflux severe). In February 2021, the patient experienced DRY EYE (Dry eyes). On an unknown date, the patient experienced IRRITABLE BOWEL SYNDROME (Irritable bowel syndrome). The patient was treated with FAMOTIDINE (PEPCID AC) at a dose of 40 mg. At the time of the report, DRY EYE (Dry eyes), RETINAL MIGRAINE (occular migraines), GASTROOESOPHAGEAL REFLUX DISEASE (reflux severe) and IRRITABLE BOWEL SYNDROME (Irritable bowel syndrome) had not resolved. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Colonoscopy: normal (normal) normal. On an unknown date, Endoscopy: normal (normal) normal. Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up information received contains added events: irritable bowl syndrome, dizziness, stomach pain, reflux severe and added concomitant and treatment medication. Lab tests: Colonoscopy, endoscopy, CT scan and high resolution manometry test are added

Other Meds: ARMOUR THYROID; ACEBUTOLOL; AMLODIPINE; CALCIUM & VITAMIN D [CALCIUM LACTATE;CALCIUM PHOSPHATE;COLECALCIFEROL]; ZINC + VITAMIN C

Current Illness: Drug allergy; Hashimoto's disease; Migraine; Raynaud's syndrome

ID: 1555370
Sex: M
Age:
State: FL

Vax Date: 01/07/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: A spontaneous report was received from a Consumer concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events diagnosed of positive covid-19 after getting the first dose of moderna coivd-19 vaccine. The patient's medical history was not provided. No relevant concomitant medications were reported. On 7 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection. Diagnosed of positive COVID-19 after getting the first dose of Moderna COIVD-19 vaccine. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), diagnosed of positive covid-19 after getting the first dose of moderna coivd-19 vaccine was unknown.

Other Meds:

Current Illness:

ID: 1555371
Sex: F
Age: 73
State: WA

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain; fever; soreness on her arm; feels hungry more than normal; A spontaneous report was received from a Consumer concerning a 73-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events pain, fever and soreness on her arm, feels hungry more than normal. The patient's medical history was not provided. Concomitant medications reported were Losartan 25mg for drug use for unknown indication. On 3 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 007m20a) intramuscularly for prophylaxis of COVID-19 infection. On 3 Feb 2021, the patient experienced the events pain. fever and soreness on her arm, feels hungry more than normal. Treatment details included Ibuprofen 200mg Action taken with mRNA-1273 in response to the events was not reported. On an unknown date the outcome of events, pain, On an unknown date the outcome of events, fever and soreness on her arm, On an unknown date the outcome of events, feels hungry more than normal was not reported.

Other Meds: LOSARTAN

Current Illness:

ID: 1555372
Sex: F
Age:
State: TX

Vax Date: 01/27/2021
Onset Date: 02/04/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itching at the injection site; pain at Injection site; redness at the injection site; swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE PAIN (pain at Injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE PAIN (pain at Injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site). At the time of the report, VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE PAIN (pain at Injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication information was provided. No treatment medication information was provided.

Other Meds:

Current Illness:

ID: 1555373
Sex: M
Age: 93
State: WA

Vax Date: 02/23/2021
Onset Date: 02/23/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: terrible night; fever; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (terrible night), PYREXIA (fever) and VOMITING (vomiting) in a 93-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced FEELING ABNORMAL (terrible night), PYREXIA (fever) and VOMITING (vomiting). At the time of the report, FEELING ABNORMAL (terrible night) outcome was unknown and PYREXIA (fever) and VOMITING (vomiting) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment related information has been reported.

Other Meds:

Current Illness:

ID: 1555374
Sex: F
Age: 83
State: FL

Vax Date: 01/28/2021
Onset Date: 01/29/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain at injection site; Red area/redness almost gone but she feels it there; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE ERYTHEMA (Red area/redness almost gone but she feels it there) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure abnormal, High cholesterol and Acid reflux (esophageal). On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE ERYTHEMA (Red area/redness almost gone but she feels it there). At the time of the report, VACCINATION SITE PAIN (Pain at injection site) outcome was unknown and VACCINATION SITE ERYTHEMA (Red area/redness almost gone but she feels it there) was resolving. The concomitant medications included blood thinner pills, blood pressure pills, high cholesterol pills, medication for reflux. The patient did not take any treatment for adverse events.

Other Meds:

Current Illness: Acid reflux (esophageal); Blood pressure abnormal; High cholesterol

ID: 1555375
Sex: F
Age: 85
State: PA

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tripped over something in house; Extreme pain in back of arm in the muscle; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Tripped over something in house) and MYALGIA (Extreme pain in back of arm in the muscle) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. No Medical History information was reported. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced MYALGIA (Extreme pain in back of arm in the muscle). On an unknown date, the patient experienced FALL (Tripped over something in house). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) for Pain, at an unspecified dose and frequency. At the time of the report, FALL (Tripped over something in house) outcome was unknown and MYALGIA (Extreme pain in back of arm in the muscle) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.

Other Meds:

Current Illness:

ID: 1555376
Sex: F
Age: 92
State: TX

Vax Date: 01/06/2021
Onset Date: 02/03/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: soreness when touched; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (soreness when touched) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0BM201A and 027L20A) for COVID-19 vaccination. No Medical History information was reported. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced INJECTION SITE PAIN (soreness when touched). At the time of the report, INJECTION SITE PAIN (soreness when touched) had not resolved. Action taken with mRNA-1273 in response to the drug was not applicable. No concomitant medication information was provided. No treatment medication information was provided. The patient reported soreness when touched (around the injection site) symptom started when given the shot, and symptoms is still going on.

Other Meds:

Current Illness:

ID: 1555377
Sex: M
Age:
State: TX

Vax Date: 02/03/2021
Onset Date: 02/04/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever 102.5; Chills; Felt like really groggy, drowsy, was really sleepy; Arm swelling; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swelling), SOMNOLENCE (Felt like really groggy, drowsy, was really sleepy), PYREXIA (Fever 102.5) and CHILLS (Chills) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PERIPHERAL SWELLING (Arm swelling). On 06-Feb-2021, the patient experienced SOMNOLENCE (Felt like really groggy, drowsy, was really sleepy). On 07-Feb-2021, the patient experienced PYREXIA (Fever 102.5) and CHILLS (Chills). At the time of the report, PERIPHERAL SWELLING (Arm swelling), SOMNOLENCE (Felt like really groggy, drowsy, was really sleepy), PYREXIA (Fever 102.5) and CHILLS (Chills) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Feb-2021, Body temperature: 102.5 (High) 102.5. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment related information has been reported.

Other Meds:

Current Illness:

ID: 1555378
Sex: F
Age: 77
State: FL

Vax Date: 01/26/2021
Onset Date: 02/03/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Little swelling; Red circle 1 and 3/4 inches down her arm and it was hot to touch; red circle 1 and 3/4 inches down her arm and it was hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (red circle 1 and 3/4 inches down her arm and it was hot to touch), VACCINATION SITE SWELLING (Little swelling) and VACCINATION SITE ERYTHEMA (Red circle 1 and 3/4 inches down her arm and it was hot to touch) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. No Medical History information was reported. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE WARMTH (red circle 1 and 3/4 inches down her arm and it was hot to touch) and VACCINATION SITE ERYTHEMA (Red circle 1 and 3/4 inches down her arm and it was hot to touch). On 05-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Little swelling). On 04-Feb-2021, VACCINATION SITE WARMTH (red circle 1 and 3/4 inches down her arm and it was hot to touch) and VACCINATION SITE ERYTHEMA (Red circle 1 and 3/4 inches down her arm and it was hot to touch) had resolved. At the time of the report, VACCINATION SITE SWELLING (Little swelling) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1555379
Sex: U
Age:
State: AL

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itching (itch) (just started 3 or 4 days ago) on back of neck; welted up; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching (itch) (just started 3 or 4 days ago) on back of neck) and URTICARIA (welted up) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Surgery (Neck surgery). On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching (itch) (just started 3 or 4 days ago) on back of neck) and URTICARIA (welted up). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (itching (itch) (just started 3 or 4 days ago) on back of neck) and URTICARIA (welted up) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1555380
Sex: F
Age:
State: NH

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: diarrhoea; Stomach cramps; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhoea) and ABDOMINAL PAIN UPPER (Stomach cramps) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhoea) and ABDOMINAL PAIN UPPER (Stomach cramps). At the time of the report, DIARRHOEA (diarrhoea) and ABDOMINAL PAIN UPPER (Stomach cramps) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment related information has been reported.

Other Meds:

Current Illness:

ID: 1555381
Sex: F
Age: 72
State: IN

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: days/couple weeks she found a red patch on left arm; Felt a little warm the second day of first dose (left arm); soreness after first dose (left arm); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness after first dose (left arm)), VACCINATION SITE WARMTH (Felt a little warm the second day of first dose (left arm)) and ERYTHEMA (days/couple weeks she found a red patch on left arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. Concomitant products included BUDESONIDE (PULMICORT) for Asthma, OLMESARTAN for Blood pressure abnormal, MIRTAZAPINE for Insomnia NOS, ASCORBIC ACID, TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC (AREDS) for Macular degeneration, BUPROPION HYDROCHLORIDE (WELLBUTRIN), BIFIDOBACTERIUM LACTIS (PROBIOTIC [BIFIDOBACTERIUM LACTIS]), MONTELUKAST, CALCIUM, OMEGA-3 [OMEGA-3 NOS] and MULTIVITAMINS [VITAMINS NOS] for an unknown indication. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (soreness after first dose (left arm)). On 27-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Felt a little warm the second day of first dose (left arm)). On an unknown date, the patient experienced ERYTHEMA (days/couple weeks she found a red patch on left arm). At the time of the report, PAIN IN EXTREMITY (soreness after first dose (left arm)), VACCINATION SITE WARMTH (Felt a little warm the second day of first dose (left arm)) and ERYTHEMA (days/couple weeks she found a red patch on left arm) outcome was unknown. Early morning on 24Feb2021(2 extra strength Tylenol) night on 23Feb2021 took (2 extra strength Tylenol) on 23Feb2021 took (2 Extra Strength Tylenol) mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. No treatment medications were reported.

Other Meds: WELLBUTRIN; PULMICORT; OLMESARTAN; AREDS; PROBIOTIC [BIFIDOBACTERIUM LACTIS]; MONTELUKAST; CALCIUM; OMEGA-3 [OMEGA-3 NOS]; MULTIVITAMINS [VITAMINS NOS]; MIRTAZAPINE

Current Illness:

ID: 1555382
Sex: F
Age: 34
State: PR

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: lost appetite; sore throat; muscle pain; lot of headache; nausea; fever goes up and down; tiredness; could not get up, could not walk because of muscle pain; just arm pain / pain in her arm; This spontaneous case was reported by a physician and describes the occurrence of GAIT DISTURBANCE (could not get up, could not walk because of muscle pain), DECREASED APPETITE (lost appetite), OROPHARYNGEAL PAIN (sore throat), MYALGIA (muscle pain) and HEADACHE (lot of headache) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. . On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Jan-2021, the patient experienced VACCINATION SITE PAIN (just arm pain / pain in her arm). On 04-Feb-2021, the patient experienced GAIT DISTURBANCE (could not get up, could not walk because of muscle pain). On an unknown date, the patient experienced DECREASED APPETITE (lost appetite), OROPHARYNGEAL PAIN (sore throat), MYALGIA (muscle pain), HEADACHE (lot of headache), NAUSEA (nausea), PYREXIA (fever goes up and down) and FATIGUE (tiredness). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, GAIT DISTURBANCE (could not get up, could not walk because of muscle pain), DECREASED APPETITE (lost appetite), OROPHARYNGEAL PAIN (sore throat), MYALGIA (muscle pain), HEADACHE (lot of headache), NAUSEA (nausea), PYREXIA (fever goes up and down), FATIGUE (tiredness) and VACCINATION SITE PAIN (just arm pain / pain in her arm) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1555383
Sex: F
Age:
State: OK

Vax Date: 02/20/2021
Onset Date: 02/22/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Flu like symptoms; Cant breath well; Dry throat, need to drink water; Mild fever (99.7F); Runny nose that goes to my throat and bothers; Headache; Arm hurting; A spontaneous report was received from a consumer concerning a 81-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events mild fever (99.7f)/pyrexia, flu like symptoms/influenza like illness, runny nose that went to throat and bothered /rhinorrhea, couldnt breath well/dyspnea, dry throat needed to drink water/dry throat, headache, arm hurting/pain in extremity. The patient's medical history was not provided. Concomitant medications reported were fexofenadine hydrochloride, unspecified blood pressure, diabetes medications. On 19 Jan 2021, the patient received first of two planned doses of mRNA-1273 (lot/batch: 030L20A) in the left arm for prophylaxis of COVID-19 infection. No adverse event reported related to the first dose of vaccine. On 20 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 024M20A) in the left arm for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced the events mild fever (99.7F), flu like symptoms. On 22 Feb 2021, the patient experienced the events headache, arm hurting. On 23 Feb 2021, the patient experienced the events runny nose that went to her throat and bothered, she couldn't breath well, had dry throat, needed to drink water. Treatment details included Tylenol. Since patient received both the scheduled doses of vaccine action taken with mRNA-1273 in response to the events was not applicable. The outcome of events mild fever (99, 7f), flu like symptoms, runny nose that goes to my throat and bothers, cant breath well, dry throat, need to drink water, headache, arm hurting was unknown.

Other Meds: ALLEGRA

Current Illness: Allergy (Unspecified allergy); Diabetes

ID: 1555384
Sex: F
Age: 82
State: FL

Vax Date: 02/23/2021
Onset Date: 02/23/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: She thinks some vaccine leaked on her/ Liquid run down my arm; She thinks some vaccine leaked on her; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (She thinks some vaccine leaked on her/ Liquid run down my arm) and DEVICE CONNECTION ISSUE (She thinks some vaccine leaked on her) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced UNDERDOSE (She thinks some vaccine leaked on her/ Liquid run down my arm) and DEVICE CONNECTION ISSUE (She thinks some vaccine leaked on her). On 23-Feb-2021, UNDERDOSE (She thinks some vaccine leaked on her/ Liquid run down my arm) and DEVICE CONNECTION ISSUE (She thinks some vaccine leaked on her) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant and treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Significant follow up appended, Same reporter with new address and height, weight added and patient enthinic group and race provided

Other Meds:

Current Illness:

ID: 1555385
Sex: F
Age:
State: NC

Vax Date: 01/22/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: BRUISING AT THE INJECTION SITE; SWOLLEN ARM AT INJECTION SITE; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (SWOLLEN ARM AT INJECTION SITE) and VACCINATION SITE BRUISING (BRUISING AT THE INJECTION SITE) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (SWOLLEN ARM AT INJECTION SITE) and VACCINATION SITE BRUISING (BRUISING AT THE INJECTION SITE). At the time of the report, VACCINATION SITE SWELLING (SWOLLEN ARM AT INJECTION SITE) and VACCINATION SITE BRUISING (BRUISING AT THE INJECTION SITE) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication were not reported. treatment information was not provided.

Other Meds:

Current Illness:

ID: 1555386
Sex: F
Age: 40
State: NE

Vax Date: 01/22/2021
Onset Date: 02/20/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Muscle pain; headache she couldn't move; aches; sick; chills; very tired, she cant do anything; sweat; body aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), PAIN IN EXTREMITY (aches), HYPERHIDROSIS (sweat), ASTHENIA (sick) and FATIGUE (very tired, she cant do anything) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Thyroid disorder. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced PAIN (body aches), HYPERHIDROSIS (sweat), FATIGUE (very tired, she cant do anything) and PYREXIA (fever). On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (aches), ASTHENIA (sick), HEADACHE (headache she couldn't move) and CHILLS (chills). On 24-Feb-2021, the patient experienced MYALGIA (Muscle pain). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (body aches), PAIN IN EXTREMITY (aches), HYPERHIDROSIS (sweat), ASTHENIA (sick), FATIGUE (very tired, she cant do anything), HEADACHE (headache she couldn't move), MYALGIA (Muscle pain), PYREXIA (fever) and CHILLS (chills) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.8 (High) 101.8?F. Concomitant medication included Thyroids pills, slow dose, The patient reported that she had pretty good immune system.

Other Meds:

Current Illness: Thyroid disorder

ID: 1555387
Sex: F
Age: 73
State: NJ

Vax Date: 02/23/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: very dizziness; arm is swollen up (L arm, injection site); chills like a flu; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (very dizziness), VACCINATION SITE SWELLING (arm is swollen up (L arm, injection site)) and CHILLS (chills like a flu) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes mellitus. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (very dizziness), VACCINATION SITE SWELLING (arm is swollen up (L arm, injection site)) and CHILLS (chills like a flu). At the time of the report, DIZZINESS (very dizziness), VACCINATION SITE SWELLING (arm is swollen up (L arm, injection site)) and CHILLS (chills like a flu) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitantly, patient was taking medication for diabetes type 2. No treatment related information has been reported. Reporter did not allow further contact

Other Meds:

Current Illness: Diabetes mellitus

ID: 1555388
Sex: M
Age: 78
State: IL

Vax Date: 02/11/2021
Onset Date: 02/12/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Diagnosed with "dry eyes" by Optometrist; Felt "Something in left eye and right eye; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of OCULAR DISCOMFORT (Felt "Something in left eye and right eye) and DRY EYE (Diagnosed with "dry eyes" by Optometrist) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Hypertension. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced OCULAR DISCOMFORT (Felt "Something in left eye and right eye). On 16-Feb-2021, the patient experienced DRY EYE (Diagnosed with "dry eyes" by Optometrist). At the time of the report, OCULAR DISCOMFORT (Felt "Something in left eye and right eye) and DRY EYE (Diagnosed with "dry eyes" by Optometrist) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications included medications for high blood pressure. Treatment medication included no tears eye drops.

Other Meds:

Current Illness: Hypertension

ID: 1555389
Sex: M
Age: 79
State: AZ

Vax Date: 01/22/2021
Onset Date: 02/04/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchiness; Rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness) and RASH (Rash) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PRURITUS (Itchiness) and RASH (Rash). At the time of the report, PRURITUS (Itchiness) and RASH (Rash) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1555390
Sex: M
Age: 74
State: TX

Vax Date: 02/23/2021
Onset Date: 02/23/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Has periods of tremulousness in same injection site arm; shoulder is aching this morning at the injection site; uncomfortable overnight period; This spontaneous case was reported by an other health care professional and describes the occurrence of DISCOMFORT (uncomfortable overnight period), TREMOR (Has periods of tremulousness in same injection site arm) and ARTHRALGIA (shoulder is aching this morning at the injection site) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced DISCOMFORT (uncomfortable overnight period). On 24-Feb-2021, the patient experienced TREMOR (Has periods of tremulousness in same injection site arm) and ARTHRALGIA (shoulder is aching this morning at the injection site). At the time of the report, DISCOMFORT (uncomfortable overnight period), TREMOR (Has periods of tremulousness in same injection site arm) and ARTHRALGIA (shoulder is aching this morning at the injection site) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1555391
Sex: F
Age: 42
State: MS

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extremely watery bowel movements; Very unpleasant smell when belches; Arm pain; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Extremely watery bowel movements), ERUCTATION (Very unpleasant smell when belches), PAIN IN EXTREMITY (Arm pain), PYREXIA (Fever) and CHILLS (Chills) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm pain), PYREXIA (Fever) and CHILLS (Chills). On 20-Jan-2021, the patient experienced DIARRHOEA (Extremely watery bowel movements) and ERUCTATION (Very unpleasant smell when belches). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO-BISMOL) ongoing since an unknown date at an unspecified dose and frequency. On 20-Jan-2021, PYREXIA (Fever) had resolved. On 21-Jan-2021, PAIN IN EXTREMITY (Arm pain) had resolved. At the time of the report, DIARRHOEA (Extremely watery bowel movements) was resolving and ERUCTATION (Very unpleasant smell when belches) and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The concomitant medications were not provided.

Other Meds:

Current Illness:

ID: 1555392
Sex: F
Age: 64
State: TX

Vax Date: 02/24/2021
Onset Date: 02/01/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; Diarrhea; Headache; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Sore arm), DIARRHOEA (Diarrhea), HEADACHE (Headache) and VOMITING (Vomiting) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022m20a) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PAIN (Sore arm), DIARRHOEA (Diarrhea), HEADACHE (Headache) and VOMITING (Vomiting). At the time of the report, PAIN (Sore arm), DIARRHOEA (Diarrhea), HEADACHE (Headache) and VOMITING (Vomiting) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1555393
Sex: F
Age: 87
State:

Vax Date: 02/22/2021
Onset Date: 02/23/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache in right side of eye; Didn't fall completely but I tripped over; Body aches; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (Didn't fall completely but I tripped over), MYALGIA (Body aches), VACCINATION SITE PAIN (Sore arm) and HEADACHE (Headache in right side of eye) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Glaucoma. Concomitant products included TRAVOPROST (TRAVATAN Z), APIXABAN (ELIQUIS), METOPROLOL SUCCINATE (TOPROL XL), AMLODIPINE BESILATE (NORVASC) and ALBUTEROL [SALBUTAMOL] for an unknown indication. On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced BALANCE DISORDER (Didn't fall completely but I tripped over), MYALGIA (Body aches) and VACCINATION SITE PAIN (Sore arm). On an unknown date, the patient experienced HEADACHE (Headache in right side of eye). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BALANCE DISORDER (Didn't fall completely but I tripped over), MYALGIA (Body aches), VACCINATION SITE PAIN (Sore arm) and HEADACHE (Headache in right side of eye) outcome was unknown. Other treatment information included cold pack and heat pack. Action taken with mRNA-1273 in response to the events was not applicable. Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds: TRAVATAN Z; ELIQUIS; TOPROL XL; NORVASC; ALBUTEROL [SALBUTAMOL]

Current Illness: Glaucoma

ID: 1555394
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pregnant; This spontaneous retrospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (pregnant). At the time of the report, EXPOSURE DURING PREGNANCY (pregnant) outcome was unknown. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1555395
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Allergic reaction; Itch 3 inches long and 2 inches wide; Redness and an itch 3 inches long and 2 inches wide; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Allergic reaction), VACCINATION SITE PRURITUS (Itch 3 inches long and 2 inches wide) and VACCINATION SITE ERYTHEMA (Redness and an itch 3 inches long and 2 inches wide) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Allergic reaction), VACCINATION SITE PRURITUS (Itch 3 inches long and 2 inches wide) and VACCINATION SITE ERYTHEMA (Redness and an itch 3 inches long and 2 inches wide). At the time of the report, HYPERSENSITIVITY (Allergic reaction), VACCINATION SITE PRURITUS (Itch 3 inches long and 2 inches wide) and VACCINATION SITE ERYTHEMA (Redness and an itch 3 inches long and 2 inches wide) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. Treatment medication was not provided.

Other Meds:

Current Illness:

ID: 1555396
Sex: F
Age: 70
State:

Vax Date: 02/13/2021
Onset Date: 02/16/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Kidney Pain; This spontaneous case was reported by a consumer and describes the occurrence of RENAL PAIN (Kidney Pain) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015m20a) for COVID-19 vaccination. No Medical History information was reported. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced RENAL PAIN (Kidney Pain). At the time of the report, RENAL PAIN (Kidney Pain) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1555397
Sex: M
Age: 70
State: CA

Vax Date: 01/26/2021
Onset Date: 02/01/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain in the right calf. Pain in the right inner thigh area; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the right calf. Pain in the right inner thigh area) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. Concurrent medical conditions included Arthritis and Prostatitis, unspecified (Prostrate problems). Concomitant products included TAMSULOSIN HYDROCHLORIDE (FLOMAX RELIEF) for Prostatitis, unspecified. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in the right calf. Pain in the right inner thigh area). At the time of the report, PAIN IN EXTREMITY (Pain in the right calf. Pain in the right inner thigh area) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not provided. Patient reported that, he was taking tamsulosin for prostrate problems, but had stopped before vaccination. Patient experienced difficulty in urination, post vaccination therefore patient started tamsulosin again. Patient also reported that the events started before , he started taking Tamsulosin.

Other Meds: FLOMAX RELIEF

Current Illness: Arthritis; Prostatitis, unspecified (Prostrate problems)

ID: 1555398
Sex: M
Age: 66
State: NY

Vax Date: 02/14/2021
Onset Date: 02/14/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: difficulty swallowing; throat felt uncomfortable; pink eye; Weak; He was having a lot of asthma symptoms/asthma was worse; dizzy; slight fever; This spontaneous case was reported by a consumer and describes the occurrence of CONJUNCTIVITIS (pink eye), OROPHARYNGEAL DISCOMFORT (throat felt uncomfortable), ASTHENIA (Weak), DYSPHAGIA (difficulty swallowing) and CONDITION AGGRAVATED (He was having a lot of asthma symptoms/asthma was worse) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Co-suspect product included non-company product ALBUTEROL [SALBUTAMOL] for Asthma. Concurrent medical conditions included Asthma. On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started ALBUTEROL [SALBUTAMOL] (unknown route) at an unspecified dose. On 14-Feb-2021, the patient experienced ASTHENIA (Weak), CONDITION AGGRAVATED (He was having a lot of asthma symptoms/asthma was worse), DIZZINESS (dizzy) and PYREXIA (slight fever). On 19-Feb-2021, the patient experienced CONJUNCTIVITIS (pink eye). On 21-Feb-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (throat felt uncomfortable) and DYSPHAGIA (difficulty swallowing). On 22-Feb-2021, ASTHENIA (Weak), DIZZINESS (dizzy) and PYREXIA (slight fever) had resolved. On 23-Feb-2021, OROPHARYNGEAL DISCOMFORT (throat felt uncomfortable) and DYSPHAGIA (difficulty swallowing) had resolved. At the time of the report, CONJUNCTIVITIS (pink eye) and CONDITION AGGRAVATED (He was having a lot of asthma symptoms/asthma was worse) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness: Asthma

ID: 1555399
Sex: M
Age: 75
State: GA

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Minor discomfort on injection Site; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (Minor discomfort on injection Site) and MYALGIA (muscle aches) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. Concurrent medical conditions included Seasonal allergy. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE, PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE (BENADRYL ALLERGY & COLD) and MOMETASONE FUROATE (FLONASE [MOMETASONE FUROATE]) for an unknown indication. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE DISCOMFORT (Minor discomfort on injection Site) and MYALGIA (muscle aches). On 01-Feb-2021, VACCINATION SITE DISCOMFORT (Minor discomfort on injection Site) and MYALGIA (muscle aches) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: BENADRYL ALLERGY & COLD; FLONASE [MOMETASONE FUROATE]

Current Illness: Seasonal allergy

ID: 1555400
Sex: F
Age: 78
State: TX

Vax Date: 02/12/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: redness; itching; rash; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness), PRURITUS (itching), RASH (rash) and FATIGUE (fatigue) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (redness), PRURITUS (itching), RASH (rash) and FATIGUE (fatigue). At the time of the report, ERYTHEMA (redness), PRURITUS (itching), RASH (rash) and FATIGUE (fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1555401
Sex: M
Age: 66
State: ID

Vax Date: 02/23/2021
Onset Date: 02/23/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hardness; Pain at injection site; Swelling 6x4 inches wide; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Hardness), VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE SWELLING (Swelling 6x4 inches wide) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE INDURATION (Hardness), VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE SWELLING (Swelling 6x4 inches wide). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE INDURATION (Hardness), VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE SWELLING (Swelling 6x4 inches wide) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1555402
Sex: F
Age: 90
State: MA

Vax Date: 02/06/2021
Onset Date: 02/07/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vaccination site pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. Concurrent medical conditions included Shingles and Diabetes. Concomitant products included GABAPENTIN and PARACETAMOL (TYLENOL) for an unknown indication. On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, VACCINATION SITE PAIN (Vaccination site pain) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: GABAPENTIN; TYLENOL

Current Illness: Diabetes; Shingles

ID: 1555403
Sex: M
Age:
State: MD

Vax Date: 01/22/2021
Onset Date: 01/29/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: night sweat; tension in neck; dizziness in the morning; pain on the site of injection; muscle pain; lymph node swollen left more inflamed than right; headache; This spontaneous case was reported by a consumer and describes the occurrence of NIGHT SWEATS (night sweat), NECK PAIN (tension in neck), DIZZINESS (dizziness in the morning), VACCINATION SITE PAIN (pain on the site of injection) and MYALGIA (muscle pain) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced NIGHT SWEATS (night sweat), NECK PAIN (tension in neck), DIZZINESS (dizziness in the morning), VACCINATION SITE PAIN (pain on the site of injection), MYALGIA (muscle pain), LYMPHADENOPATHY (lymph node swollen left more inflamed than right) and HEADACHE (headache). On 04-Feb-2021, HEADACHE (headache) had resolved. At the time of the report, NIGHT SWEATS (night sweat), NECK PAIN (tension in neck), DIZZINESS (dizziness in the morning), VACCINATION SITE PAIN (pain on the site of injection), MYALGIA (muscle pain) and LYMPHADENOPATHY (lymph node swollen left more inflamed than right) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications reported by investigator o No treatment medications provided by the reporter. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1555404
Sex: M
Age: 61
State: WA

Vax Date: 02/04/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: experiencing headache; a bit of a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (experiencing headache) and INJECTION SITE PAIN (a bit of a sore arm) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (experiencing headache) and INJECTION SITE PAIN (a bit of a sore arm). At the time of the report, HEADACHE (experiencing headache) and INJECTION SITE PAIN (a bit of a sore arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1555405
Sex: F
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Reactions due to polyethylene glycol; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (Reactions due to polyethylene glycol) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE DRUG REACTION (Reactions due to polyethylene glycol). At the time of the report, ADVERSE DRUG REACTION (Reactions due to polyethylene glycol) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant and treatment medications were reported.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 03 October 2021 5:28pm